• Banner Newsletter Seite

NEWS DIGEST by a&r | April 2020

2020-04-30T13:33:46+02:00

We dedicate this April issue to a&r’s VIRTUAL EVENT which will be held online in May from the 4 to the 22 May. Join us online and get access to exclusive content!

SUBSCRIBE

Invitation to a&r VIRTUAL EVENT

a&r virtual event

Due to COVID-19 many important industry events and trade shows were cancelled or postponed.

As an alternative to stay in touch, a&r is hosting a virtual nutraceutical event, where you can engage with a&r experts on trending topics and schedule a dedicated consulting meeting to discuss topics that matter to you and your business.

From 4 to 22 May, please join us online and get access to exclusive content.

We are offering:

  • Personal consulting meetings with our experts to address your individual needs. Slots of 15 minutes will be offered every afternoon, from 1 pm to 6 pm CEST (pre-booking required).
  • 5 webinars where we share our expert knowledge on trending industry topics.
VIEW FULL PROGRAM AND REGISTER FOR FREE!

Regulatory News

Vitamin D recommendations and food authorities’ concerns with food supplement claims during COVID-19

It is well known that vitamin D plays a key role in maintaining bone and muscle tissue as well as boosting the immune system. Recently, there have been news about vitamin D reducing the risk of coronavirus. In the last 2 months, 12 scientific publications have been published on this topic on PubMed. However, there is still no evidence that this is the case.

A recent recommendation by the French Food Agency (ANSES), advises people to ensure a sufficient vitamin D intake through diet during COVID-19 lockdown. ANSES is reiterating the importance of ensuring sufficient intake of vitamin D (not only during the current lockdown but all year round), particularly for older people, people with darker skin tones, and menopausal women. Nevertheless, the French authority mentions that food supplements for offsetting a possible inadequate vitamin D intake should only be taken on dietary or medical advice. In most cases, vitamin D can be obtained through a balanced diet and sun exposure. In contrast, in the UK the NHS has advised people to consider taking 10 micrograms of vitamin D a day to keep bones and muscles healthy. This is because, during the lockdown, people may not be getting enough vitamin D from sunlight as they are indoors most of the day.

In parallel, the French Food Agency (ANSES) has raised concerns against food supplements containing plants with anti-inflammatory properties that could act as non-steroidal anti-inflammatory drugs (NSAIDs) in particular in people infected with COVID-19. Thus, and in the light of the COVID-19 epidemic, ANSES issued an internal request regarding the risks associated with taking food supplements containing plants that could interfere with the body’s immune and inflammatory response in fighting infection by the coronavirus SARS-CoV-2. A number of plants have been identified as having a counter-productive effect on the body’s natural defenses against the coronavirus. The identified plants were plants containing salicylic acid derivatives, similar to aspirin, such as willow, meadowsweet, birch, poplar, goldenrod and polygala, as well as plants containing other herbal anti-inflammatories, such as harpagophytum, echinacea, turmeric, and cat’s claw, and plants of the genera Boswellia and Commiphora.

In parallel, the Norwegian Food Safety Authority (Mattilsynet) has also raised concerns with supplements that claim to have an effect on e.g. providing a stronger immune system, to help reduce inflammation or prevent people from being infected by the coronavirus. In times like the one we are currently living, it is important not to mislead consumers with unsubstantiated claims.

NutraBusiness Intel

Cambridge Commodities expands in the US with the acquisition of US organic ingredient company

Cambridge Commodities, a supplier of nutritional ingredients and product solutions to the sports nutrition, food and beverage, animal nutrition, and health and wellbeing industries, has acquired the US-based ingredient supplier, Ultimate Superfoods for an undisclosed amount. The acquisition will provide Ultimate Superfoods with access to Cambridge Commodities’ approved supplier base of nutritional ingredients, its new product development expertise, and their technical teams, while further expanding the Cambridge Commodities footprint in the US.

6 April 2020 • Source

Ingredion to acquire controlling stake in PureCircle

Ingredion, a global ingredient manufacturer, has struck a deal to acquire a controlling (75%) stake in stevia supplier PureCircle. The proposed acquisition has been approved by the boards of both companies. The companies expect the transaction to be closed during the second half of 2020 but it is still subject to approval by PureCircle’s shareholders and receipt of the required regulatory approvals.

9 April 2020 • Source

LNC Therapeutics announces exclusive license agreement with CSIC for Christensenella gut bacteria for mood disorders

LNC Therapeutics, a French biotech company specializing in the research and development of innovative drugs harnessing the potential of the gut microbiome, entered into an exclusive license agreement with Spanish National Research Council (CSIC), for its patent dedicated to the therapeutic applications of Christensenella gut bacteria in mood disorders. The deal will strengthen LNC’s portfolio of intellectual property and live biotherapeutic products for new applications in areas of high unmet medical needs.

15 April 2020 • Source

Chr. Hansen acquires HSO Health Care to grow probiotics offering for women’s health

Chr. Hansen Holding A/S has entered into an agreement to acquire Austria-based B2B company HSO Health Care, a specialist in probiotics for women’s health. This acquisition will strengthen and expand Chr. Hansen’s global microbial platform and the fast-growing category for women’s health.

20 April 2020 • Source

Ceres Pharma acquires Viva Pharma

The Belgian pharmaceutical company Ceres Pharma has completed the acquisition of the Romanian firm Viva Pharma. The price of the takeover was not disclosed.

Viva Pharma is a marketing and sales company active in dietary supplements, derma-cosmetics, and medical devices. Some of the important Viva Pharma brands are SantaDerm®, SantaDerm® ParasiteS, SeptiMar, SeptiClean®, LaxaClean and Mobilin.

23 April 2020 • Source

Orifarm acquires OTC portfolio from Takeda

Orifarm Group (“Orifarm”), a supplier of parallel imported pharmaceuticals in the EU, has entered into an agreement to purchase a portfolio of selected OTC and prescription pharmaceutical products sold in Europe from Takeda in a deal worth approximately €615 million. The acquisition includes approximately 110 pharmaceuticals and dietary supplements. The deal will strengthen Orifam’s presence in its key markets and expansion into new geographical markets.

24 April 2020 • Source

MatchMaking banner newsletter

Your experts

Irene Wohlfahrt
Irene WohlfahrtSenior Consultant
Dr. Inês Rocha
Dr. Inês RochaDirector of Business Development and Strategic Innovation

At analyze & realize, we are experts in the field of natural health products, having provided our services for more than 20 years. We offer a unique combination of expertise in natural health products through our scientific, regulatory, and strategic innovation consulting and our clinical research organization with its own clinical trial center in Berlin, Germany. Thanks to our close interaction with the natural product market as well as our extensive network, we are always at the forefront of the latest information and innovation trends. With its international team of 35 employees, a&r is a leading European one-stop-shop ready to guide and support your needs in natural health product innovation.

Don’t hesitate to contact us: newsletter@a-r.com